当前位置: 首页 > 详情页

Soy Isoflavone Antagonizes the Oxidative Cerebrovascular Injury Induced by beta-Amyloid Peptides 1-42 in Rats

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]School of Public Health, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing, People’s Republic of China [2]Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, People’s Republic of China [3]Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, People’s Republic of China
出处:
ISSN:

关键词: Soy isoflavone beta-Amyloid peptide 1-42 Cerebrovascular Nrf2 signaling pathway Keap1 Neuroprotection

摘要:
Numerous evidences have shown that the antioxidative properties of soy isoflavone (SIF) have beneficial effects on prophylaxis of neurodegeneration, however, the mechanism is still not fully illustrated. As cerebrovascular dysfunction could initiate a cascade of events leading to pathogenesis of Alzheimer's disease, we tried to investigate whether SIF could protect the cerebrovascular system due to antagonizing oxidative damage induced by A beta 1-42 in present study. In addition, NF-E2-related factor 2 (Nrf2) signaling pathways in the cerebrovascular tissue of Wistar rats were investigated to identify the potential cerebrovascular protective targets of SIF. Research results showed that SIF reduced the excessive production of nitrotyrosine in cerebrovascular tissue induced by A beta 1-42, and maintained redox homeostasis by increasing the level of GSH and GSH/GSSG. Moreover, SIF could alleviate the down-regulation of Nrf2, gamma-glutamylcysteine synthetase, Heme oxygenase-1 expressions in cerebrovascular tissue induced by A beta 1-42 and suppress the increase of Kelch like ECH protein-1 (Keap1). These data suggested that SIF might reduce the cerebrovascular oxidative damage induced by A beta 1-42 through regulating the Nrf2 signaling pathway. The mechanisms of SIF modulating the potential target Nrf2 might be associated with Keap1 expression.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 3 区 医学
小类 | 4 区 生化与分子生物学 4 区 神经科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 生化与分子生物学 3 区 神经科学
JCR分区:
出版当年[2012]版:
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 NEUROSCIENCES
最新[2023]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]School of Public Health, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing, People’s Republic of China [2]Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构: [1]School of Public Health, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing, People’s Republic of China [2]Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院